Recent advances with immunotherapy in melanoma, lung, and kidney cancers have caused clinicians and patients to eagerly anticipate the results of immunotherapy studies for the treatment of additional cancers.
http://www.medscape.com/viewarticle/858258
PD-1 Inhibitors Show Promise in Upper GI Cancers